From computer vision systems for mammography to ambient listening technology for medical documentation, South Shore Health is ...

Ocular Therapeutix (OCUL) stock surges on rumors that Sanofi (SNY) is readying an improved bid to take over the company. Read ...

Calamos Global Total Return Fund remains a buy due to its deeply discounted 9.13% NAV, despite positive price momentum and robust 8% yield. Click here to read more.